Immucell Corp ICCC
$10.06
-0.30%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | FORM 10-Q | 2026-08-13 | View → |
| 8-K | FORM 8-K | 2026-08-13 | View → |
| 8-K | FORM 8-K | 2026-07-09 | View → |
| 4 | FORM 4 TE BOEKHORST, OLIVIER | 2026-06-22 | View → |
| 8-K | FORM 8-K | 2026-06-17 | View → |
| 8-K | FORM 8-K | 2026-06-10 | View → |
| 8-K | FORM 8-K | 2026-05-14 | View → |
| 10-Q | FORM 10-Q | 2026-05-14 | View → |
| 8-K | FORM 8-K | 2026-05-08 | View → |
| DEF 14A | FORM DEF 14A | 2026-04-24 | View → |
| 4 | FORM 4 TURNER, KATHY 04/15/26 | 2026-04-16 | View → |
| 4 | FORM 4, TOMSCHE, DAVID 04/15/26 | 2026-04-16 | View → |
| 4 | FORM 4 BASSE GLORIA 04/15/26 | 2026-04-16 | View → |
| 4 | FORM 4 WAINMAN, PAUL 04/15/26 | 2026-04-16 | View → |
| 4 | FORM 4 GATHAGAN, BRYAN 04/14/26 | 2026-04-14 | View → |
| 4 | FORM 4 WAINMAN, PAUL 04/16/26 | 2026-04-14 | View → |
| 4 | FORM 4 TOMSCHE, DAVID 04/14/26 | 2026-04-14 | View → |
| 4 | FORM 4 BROCKMANN, BOBBI 04/14/26 | 2026-04-14 | View → |
| 4 | FORM 4 ROSGEN, STEVEN 04/14/26 | 2026-04-14 | View → |
| 4 | FORM 4 BASSE GLORIA 04/14/26 | 2026-04-14 | View → |
| 8-K | FORM 8-K | 2026-04-14 | View → |
| 8-K | FORM 8-K | 2026-04-08 | View → |
| 10-K | FORM 10-K | 2026-03-30 | View → |
| 4 | FORM 4 | 2026-03-24 | View → |
| 8-K | FORM 8-K | 2026-03-18 | View → |
| 8-K | FORM 8-K | 2026-03-04 | View → |
| 8-K | FORM 8-K | 2026-02-09 | View → |
| 8-K | FORM 8-K | 2026-02-02 | View → |
| 4 | FORM 4 FIORI | 2026-01-29 | View → |
| 4 | FORM 4 BROCKMANN | 2026-01-29 | View → |
| 4 | FORM 4 TE BOEKHORST | 2026-01-29 | View → |
| 8-K | FORM 8-K | 2026-01-08 | View → |
| 8-K | FORM 8-K | 2025-12-29 | View → |
| 4 | FORM 4 O TE BOEKHORST | 2025-12-03 | View → |
| 4 | FORM 4 D TOMSCHE | 2025-11-28 | View → |
| 10-Q | FORM 10-Q | 2025-11-13 | View → |
| 8-K | FORM 8-K | 2025-11-13 | View → |
| 4 | FORM 4 | 2025-11-12 | View → |
| 8-K | FORM 8-K | 2025-11-04 | View → |
| 8-K | FORM 8-K EARNINGS | 2025-10-07 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $10.06
- Market Cap
- $91.37 million
- 52-Week Range
- $4.52 – $12.10
- Average Volume
- 31K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.